Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Apr 12, 2021 Form 4 Insider Report for NATURES SUNSHINE PRODUCTS INC (NATR)

Role
10%+ Owner
Signature
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., By: /s/ WU Yifang/Chairman
Stock symbol
NATR
Transactions as of
Apr 12, 2021
Transactions value $
$218,000
Form type
4
Date filed
1/24/2022, 08:56 AM
Next filing
Oct 15, 2024

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent incremental shares granted by the Issuer as an adjustment to the vested option award of a former director of the Issuer (the "Former Director"). These shares initially reported on a Form 4 filed by the Former Director, but were actually issued to Fosun Industrial Co., Limited. Due to this oversight, a Form 4 was not previously filed by the Reporting Person regarding this issuance.
F2 Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person.
F3 These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the delivery of certain vested restricted stock units that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person.
F4 These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the exercise of certain stock options (the "Options") that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person.
F5 Represents the exercise price paid by Fosun Industrial Co., Limited for the shares underlying the Options upon the exercise of the Options.